Goodrx Holdings Inc (NASDAQ:GDRX) — Market Cap & Net Worth
Market Cap & Net Worth: Goodrx Holdings Inc (GDRX)
Goodrx Holdings Inc (NASDAQ:GDRX) has a market capitalization of $275.27 Million ($275.27 Million) as of June 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #15350 globally and #3571 in its home market, demonstrating a -1.51% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Goodrx Holdings Inc's stock price $2.61 by its total outstanding shares 105468832 (105.47 Million). Review GDRX liabilities breakdown to assess the company's total debt and financial obligations.
Goodrx Holdings Inc Market Cap History: 2020 to 2026
Goodrx Holdings Inc's market capitalization history from 2020 to 2026. Data shows change from $4.25 Billion to $275.27 Million (-40.35% CAGR).
Index Memberships
Goodrx Holdings Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.42 Trillion | 0.01% | #413 of 976 |
|
NASDAQ Composite
IXIC
|
$40.74 Trillion | 0.00% | #1483 of 3165 |
Weight: Goodrx Holdings Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Goodrx Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Goodrx Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.62x
Goodrx Holdings Inc's market cap is 0.62 times its annual revenue
Latest Price to Earnings (P/E) Ratio
29.92x
Goodrx Holdings Inc's market cap is 29.92 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $4.25 Billion | $550.70 Million | -$293.62 Million | 7.73x | N/A |
| 2021 | $3.45 Billion | $745.42 Million | -$25.25 Million | 4.62x | N/A |
| 2022 | $491.48 Million | $766.55 Million | -$32.83 Million | 0.64x | N/A |
| 2023 | $706.64 Million | $750.26 Million | -$8.87 Million | 0.94x | N/A |
| 2024 | $490.43 Million | $792.32 Million | $16.39 Million | 0.62x | 29.92x |
Competitor Companies of GDRX by Market Capitalization
Companies near Goodrx Holdings Inc in the global market cap rankings as of June 19, 2026.
Key companies related to Goodrx Holdings Inc by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #1066 globally with a market cap of $25.15 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1911 globally with a market cap of $12.48 Billion USD ( AU$17.64 Billion AUD).
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2171 globally with a market cap of $10.63 Billion USD.
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2547 globally with a market cap of $8.48 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1066 | Veeva Systems Inc Class A | NYSE:VEEV | $25.15 Billion | $154.85 |
| #1911 | Pro Medicus Ltd | AU:PME | $12.48 Billion | AU$168.90 |
| #2171 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $64.43 |
| #2547 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $8.48 Billion | $48.79 |
Goodrx Holdings Inc Historical Marketcap From 2020 to 2026
Between 2020 and today, Goodrx Holdings Inc's market cap moved from $4.25 Billion to $ 275.27 Million, with a yearly change of -40.35%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $275.27 Million | -3.69% |
| 2025 | $285.82 Million | -41.72% |
| 2024 | $490.43 Million | -30.60% |
| 2023 | $706.64 Million | +43.78% |
| 2022 | $491.48 Million | -85.74% |
| 2021 | $3.45 Billion | -18.99% |
| 2020 | $4.25 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Goodrx Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $275.27 Million USD |
| MoneyControl | $275.27 Million USD |
| MarketWatch | $275.27 Million USD |
| marketcap.company | $275.27 Million USD |
| Reuters | $275.27 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Goodrx Holdings Inc
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products … Read more